Specifically, those expressing calcium binding proteins parvalbumin, calbindin and calretinin, resulting in alterations in GABAergic interneuron populations and paralleling interneuron loss in human AD patients [47]–[49]. The gene discussed is CALB2; the disease is Alzheimer disease.